Prevalence of "hidden" renal failure in the population suffering from type-2 diabetes;Prevalencia de insuficiencia renal «oculta» en población diabética tipo 2

Atencion Primaria

Volumn 35, Issue 7, 2005, Pages 359-364

  Tranche Iparraguirre, S ^a   Riesgo Garcia A ^a   Marin Iranzo R ^b   Diaz Gonzalez G ^a   Garcia Fernandez A ^a  

^a Centro de Salud El Cristo   (Spain)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

Cockcroft Gault formula; Renal failure; Type 2 diabetes

Indexed keywords

CREATININE; GLUCOSE; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; BODY MASS; BODY SURFACE; CALCULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL FEATURE; COCKCROFT GAULT FORMULA; CONFIDENCE INTERVAL; CREATININE BLOOD LEVEL; DEMOGRAPHY; DIABETES CONTROL; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEART FAILURE; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; RISK FACTOR; SEX DIFFERENCE; SPAIN; CROSS-SECTIONAL STUDY; DIABETIC NEPHROPATHY;

AGED; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; KIDNEY FAILURE; MALE; PREVALENCE;

EID: 20644454671     PISSN: 02126567     EISSN: None     Source Type: Journal    
DOI: 10.1157/13074294     Document Type: Article

References (27)

1. USA Renal Data System. USRDS 2000 Annual Data Report, National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases. Bethesda, MD; 2002.
2. Amenabar JJ, García López F, Robles NR, Saracho R, Pinilla J, Gentil MA et al. Informe de diálisis y trasplante de la Sociedad Espanola de Nefrología y registros Autonómicos, an̄o 2000. Nefrología. 2002;22:310-7.
3. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al. National Kidney Foundation Practice Guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Inter Med. 2003;139:137-47.
4. Molitch ME, Rodman E, Hirsch CA, Dubinsky E. Spurious serum creatinina elevations in ketoacidosis. Ann Intern Med. 1980;93:280-1.
5. Saah AJ, Koch TR, Drusano GL. Cefoxitin falsely elevates creatinina levels. JAMA. 1982;247:205-6.
6. Rocci ML Jr, Vlasses PH, Ferguson RK. Creatinine serum concentrations and H2-receptors antagonist. Clin Nephrol. 1984;22:214-5.
7. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31-41.
8. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999;130:461-70.
9. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-72.
10. Coresh J, Wei GL, McQuillan G, Brancati FI, Levey AS, Jones C, et al. Prevalence of high blood pressure and elevated serum creatinine level in the United States. Arch Intern Med. 2001;161:1207-16.
11. Culleton BF, Larson MG, Evans JC, Wilson PWF, Barret BJ, Parfrey PS, et al. Prevalence and correlates of elevated serum creatinine levels. The Framingham Heart Study. Arch Intern Med. 1999;1785-90.
12. Kissmeyer I, Kong C, Cohen J, Unwin RJ, Woolfson RG, Neild GH. Community nephrology: audit of screening for renal insufficiency in a high risk population. Nephrol Dial Transplant. 1999;14:2150-5.
13. Duncan L, Heathcote J, Djurdejv O, Levin A. Screening for renal disease using serum creatinine: who are we missing? Nephrol Dial Transplant. 2001;16:1042-6.
14. Fernández-Fresnedo G, De Francisco ALM, Rodrigo E, Pinera C, Herraez I, Ruiz JC, et al. Insuficiencia renal «oculta» por valoracion de la funcion renal mediante la creatinina sérica. Nefrologia. 2002;22:144-51.
15. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003;41:1-12.
16. Chadban SJ, Briganti EM, Kerr PG, Dunstan DW, Welborn TA, Zimmet PZ, et al. Prevalence of kidney damage in Australian adults: the Ausdiab Kidney Study. J Am Soc Nephrol. 2003;14:S131-8.
17. Fagnani F, Souchet T, Labed D, Gaugris S, Hannedouche T, Grimaldi A. Management of hypertension and screening of renal complications by GPs in diabetic type 2 patients (France 2001). Diabetes Metab. 2003;29:58-64.
18. Cano A, Morlans M, López A, LLosa L, López F, Espona R, et al. Prevalencia de insuficiencia renal crónica en atención primaria. Aten Primaria. 2002;29:90-6.
19. Marín R, Coca A, Tranche S, Rodríguez Mañas L, Abellán J, Moya A, en representación del Grupo de Estudio PIRDDOS. Prevalencia de la afectación renal en una poblacion de diabéticos tipo 2 seguidos en Atención Primaria. Nefrología. 2002;22:152-61.
20. Olivares J, Guillén F, Sánchez JJ, Morales Olivas FJ, en representación de los investigadores del estudio «Cuidar el riñón». Influencia de la presión arterial y la edad en la función renal. Estudio Cuidar el Riñón. Nefrología. 2003;23:137-44.
21. Mann JFE, Gerstein HC, Pogue J, Bosch J, Yusuf S, for the Hope investigators Renal Insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial. Ann Intern Med. 2001;134:629-36.
22. Ruilope LM, Salvetti A, Jamerson K, Hansson L, Warnold I, Wedel H, Zanchetti A. Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT). J Am Soc Nephrol. 2001;12:218-25.
23. Muntner P, He J, Hamm L, Loria C, Whelton PK. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol. 2002;13:745-53.
24. Manjunath G, Tighiouart H, Coresh J, MacLeod B, Salem DN, Griffith JL, et al. Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int. 2003;63: 1121-9.
25. Rahtman M, Brown CD, Coresh J, Davids BR, Echfeldt JH, Kopyt N, et al. The prevalence of reduced glomerular filtration rate in older hypertensive patients and its association with cardiovascular disease. Arch Intern Med. 2004;164:969-76.
26. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular disease. A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003;108:2154-69.
27. De Francisco ALM, Fernández-Fresnedo G. Llegada tardía a diálisis como consecuencia de insuficiencia renal no identificada. Nefrología. 2002;22:95-7.